Your browser doesn't support javascript.
loading
Determinants of exercise-induced oxygen desaturation including pulmonary emphysema in COPD: Results from the ECLIPSE study.
Andrianopoulos, Vasileios; Celli, Bartolome R; Franssen, Frits M E; Pinto-Plata, Victor M; Calverley, Peter M A; Vanfleteren, Lowie E G W; Vogiatzis, Ioannis; Vestbo, Jørgen; Agusti, Alvar; Bakke, Per S; Rennard, Stephen I; MacNee, William; Tal-Singer, Ruth; Yates, Julie C; Wouters, Emiel F M; Spruit, Martijn A.
Afiliação
  • Andrianopoulos V; Department of Research and Education, CIRO+, Centre of Expertise for Chronic Organ Failure, Horn, The Netherlands; Department of Respiratory Medicine and Pulmonary Rehabilitation, Schoen Klinik Berchtesgadener Land, Schoenau am Koenigssee, Germany. Electronic address: VAndrianopoulos@schoen-kliniken
  • Celli BR; Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: bcelli@copdnet.org.
  • Franssen FM; Department of Research and Education, CIRO+, Centre of Expertise for Chronic Organ Failure, Horn, The Netherlands. Electronic address: fritsfranssen@ciro-horn.nl.
  • Pinto-Plata VM; Department of Respiratory Medicine, School of Clinical Science, University of Liverpool, United Kingdom. Electronic address: vpinto@copdnet.org.
  • Calverley PM; Institute of Ageing and Chronic Disease, University Hospital Aintree, Liverpool, United Kingdom. Electronic address: pmacal@liverpool.ac.uk.
  • Vanfleteren LE; Department of Research and Education, CIRO+, Centre of Expertise for Chronic Organ Failure, Horn, The Netherlands; Department of Respiratory Medicine, Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands. Electronic address: lowievanfleteren@ciro-horn.nl.
  • Vogiatzis I; Department of Physical Education and Sport Sciences, National and Kapodistrian University of Athens, Greece. Electronic address: gianvog@phed.uoa.gr.
  • Vestbo J; Centre for Respiratory Medicine and Allergy, University of Manchester, UK. Electronic address: Jorgen.Vestbo@manchester.ac.uk.
  • Agusti A; Respiratory Institute, Hospital Clinic, IDIBAPS, University of Barcelona, CIBERES, Barcelona, Spain. Electronic address: alvar.agusti@clinic.ub.es.
  • Bakke PS; Department of Clinical Science, University of Bergen, Bergen, Norway. Electronic address: per.bakke@med.uib.no.
  • Rennard SI; Pulmonary and Critical Care Medicine, University of Nebraska Medical Center, Omaha, NE, USA. Electronic address: srennard@unmc.edu.
  • MacNee W; Medical Research Council Centre for Inflammation Research, University of Edinburgh, The Queen's Medical Research Institute, Edinburgh, United Kingdom. Electronic address: w.macnee@ed.ac.uk.
  • Tal-Singer R; GSK Research and Development, King of Prussia, Philadelphia, PA, USA. Electronic address: Ruth.M.Tal-Singer@gsk.com.
  • Yates JC; GSK Research Triangle Park, NC, USA. Electronic address: julie.c.yates@gsk.com.
  • Wouters EF; Department of Research and Education, CIRO+, Centre of Expertise for Chronic Organ Failure, Horn, The Netherlands; Department of Respiratory Medicine, Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands. Electronic address: e.wouters@mumc.nl.
  • Spruit MA; Department of Research and Education, CIRO+, Centre of Expertise for Chronic Organ Failure, Horn, The Netherlands; REVAL - Rehabilitation Research Center, BIOMED - Biomedical Research Institute, Faculty of Medicine and Life Sciences, Hasselt University, Diepenbeek, Belgium. Electronic address: marti
Respir Med ; 119: 87-95, 2016 10.
Article em En | MEDLINE | ID: mdl-27692154
ABSTRACT
Exercise-induced oxygen desaturation (EID) is related to mortality in patients with chronic obstructive pulmonary disease (COPD). We investigated (1) the prevalence of EID; (2) the relative-weight of several physiological determinants of EID including pulmonary emphysema, and (3) the relationship of EID with certain patients' clinical characteristics. Data from 2050 COPD patients (age 63.3 ± 7.1years; FEV1 48.7 ± 15.7%pred.) were analyzed. The occurrence of EID (SpO2post ≤88%) at the six-minute walking test (6MWT) was investigated in association with emphysema quantified by computed-tomography (QCT), and several clinical characteristics. 435 patients (21%) exhibited EID. Subjects with EID had more QCT-emphysema, lower exercise capacity and worse health-status (BODE, ADO indexes) compared to non-EID. Determinant of EID were obesity (BMI≥30 kg/m2), impaired FEV1 (≤44%pred.), moderate or worse emphysema, and low SpO2 at rest (≤93%). Linear regression indicated that each 1-point increase on the ADO-score independently elevates odds ratio (≤1.5fold) for EID. About one in five COPD patients in the ECLIPSE cohort present EID. Advanced emphysema is associated with EID. In addition, obesity, severe airflow limitation, and low resting oxygen saturation increase the risk for EID. Patients with EID in GOLD stage II have higher odds to have moderate or worse emphysema compared those with EID in GOLD stage III-IV. Emphysematous patients with high ADO-score should be monitored for EID.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oxigênio / Enfisema Pulmonar / Doença Pulmonar Obstrutiva Crônica Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Respir Med Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oxigênio / Enfisema Pulmonar / Doença Pulmonar Obstrutiva Crônica Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Respir Med Ano de publicação: 2016 Tipo de documento: Article